2025-11-10T06:50:22-06:00 2024-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2024-01-01 586032060 AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED AMER 3016347065 1801 ROCKVILLE PIKE 210 ROCKVILLE MD 20852 DAVID JACKSON EXECUTIVE OFFICER 3016347060 2025-11-04 1 1 JOSEPH J BARRECA P00310073 3019860600 2025-11-04 2024 2025-03-06 01:10:19Z DAVID JACKSON 1801 ROCKVILLE PIKE 210 ROCKVILLE MD 20852 14937215 0 X WWW.ASPET.ORG X 1933 MD THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS. 9 8 23 100 20432 14300 10917 20474 4259079 4193028 1405014 2477137 37363 43965 5712373 6734604 369000 276000 0 0 3186162 3389010 0 0 0 3589043 3695712 7144205 7360722 -1431832 -626118 30249773 31116051 3630822 4138245 26618951 26977806 X THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS. 0 0 1918957 0 3370443 PUBLICATIONS - THE SOCIETY PUBLISHES SCIENTIFIC AND EDUCATIONAL JOURNALS AND OTHER PUBLICATIONS FOR THE SCIENTIFIC COMMUNITY INCLUDING THE FOLLOWING:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - MONTHLY RESEARCH PUBLICATION COVERING TOPICS INCLUDING THE INTERACTIONS OF CHEMICALS WITH BIOLOGICAL SYSTEMS, INCLUDING AUTONOMIC, BEHAVIORAL, CARDIOVASCULAR, CELLULAR, CLINICAL, DEVELOPMENTAL, GASTROINTESTINAL, IMMUNO-, NEURO-, PULMONARY AND RENAL PHARMACOLOGY, AS WELL AS ANALGESICS, DRUG ABUSE, METABOLISM AND DISPOSITION, CHEMOTHERAPY, AND TOXICOLOGY.PHARMACOLOGICAL REVIEWS - QUARTERLY REVIEW JOURNAL COVERING CONCENTRATIONS IN PHARMACOLOGY, EXPERIMENTAL THERAPEUTICS, TOXICOLOGY, AND CHEMOTHERAPY.MOLECULAR PHARMACOLOGY - MONTHLY PUBLICATION WITH AN EMPHASIS ON RESEARCH OF DRUG ACTION AND SELECTIVE TOXICITY AT THE MOLECULAR LEVEL. ORIGINAL APPLICATIONS OF BIOCHEMISTRY, BIOPHYSICS, GENETICS AND MOLECULAR BIOLOGY ARE COMBINED WITH PHARMACOLOGIC RESEARCH TO SOLVE BASIC PROBLEMS IN PHARMACOLOGY AND TOXICOLOGY.DRUG METABOLISM AND DISPOSITION - MONTHLY PUBLICATION COVERING THE FIELDS OF PHARMACOKINETICS, PHARMACODYNAMICS AND MECHANISMS, GENETIC NUTRITIONAL OR HORMONAL FACTORS AFFECTING THE BIOLOGICAL FATE OF CHEMICALS, AND THE TOXICOLOGICAL CONSEQUENCES OF XENOBIOTIC METABOLISM.THE PHARMACOLOGIST - MONTHLY PUBLICATION WITH THE PURPOSE OF INFORMING PHARMACOLOGISTS ABOUT SOCIETY AFFAIRS AND OTHER MATTERS OF PROFESSIONAL INTEREST. DISTRIBUTED ELECTRONICALLY TO ASPET MEMBERS AND MAILED TO NONMEMBER SUBSCRIBERS AS WELL AS MEMBERS WHO PAY FOR A PRINT SUBSCRIPTION. 1575137 0 470060 MEETINGS - THE SOCIETY HOSTS AN ANNUAL MEETING EACH YEAR IN A DIFFERENT PART OF THE US PROVIDING A FORUM FOR SCIENTISTS TO COMMUNICATE AND EXCHANGE PHARMACOLOGICAL KNOWLEDGE THROUGH SCIENTIFIC SESSIONS. SMALLER FOCUSED MEETINGS ARE HELD ON AN OCCASIONAL BASIS AS THE NEED ARISES. 596559 0 0 MARKETING - TO PROMOTE ASPET'S PROGRAMS AND SERVICES, PRODUCE THE PHARMACOLOGIST, ASPET'S MONTHLY NEWSLETTER, PROMOTE MEMBERSHIPS AND THE ANNUAL MEETING. 579747 276000 0 AWARDS - THE SOCIETY OFFERS THREE TYPES OF AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE OUTSTANDING RESEARCH BY PROMINENT PHARMACOLOGISTS AND TO STIMULATE FUNDAMENTAL RESEARCH BY YOUNG INVESTIGATORS. BEST POSTER AWARDS ARE PRESENTED TO MEETING ATTENDEES WHO HAVE SUBMITTED AN OUTSTANDING RESEARCH ABSTRACT FOR PRESENTATION AT THE MEETING. TRAVEL AWARDS ARE GRANTED TO STUDENTS AS AN EDUCATIONAL TOOL TO ATTEND SCIENTIFIC MEETINGS. 552436 0 352525 MEMBER SERVICES - INCLUDES MEMBERSHIP COMMUNICATIONS AND DIVISIONS TO ADDRESS SPECIFIC AREAS OF CONCERN OR INTEREST TO THE MEMBER PHARMACOLOGISTS IN THE SOCIETY. NOMINATION AND ELECTION OF NEW MEMBERS, DEVELOPMENT OF EDUCATIONAL ACTIVITIES RELEVANT TO THE PROMOTION AND ADVANCEMENT OF THE SCIENTIFIC DISCIPLINE. WEB SITE PROVIDES AN INTERFACE BETWEEN MEMBERS AND THE SOCIETY AS WELL AS INFORMATION TO INDIVIDUALS WISHING TO LEARN MORE ABOUT THE FIELD OF PHARMACOLOGY. 314752 0 0 PUBLIC SERVICES - PROVIDES INFORMATION TO THE GENERAL PUBLIC ABOUT PHARMACOLOGY AND SCIENTIFIC ACHIEVEMENTS AND NEEDS IN THE FIELD. OFFICERS AND MEMBERS PROVIDE A RESOURCE TO THE COMMUNITY WHEN THERE IS A NEED FOR SPECIALIZED EXPERTISE. THE EDUCATION DIVISION CONDUCTS SPECIAL SESSIONS DEVOTED TO IMPROVING EDUCATION IN THE PHARMACOLOGICAL SCIENCES. 260133 0 0 EDUCATIONAL AFFAIRS - SUPPORTS SUMMER UNDERGRADUATE RESEARCH FELLOWSHIPS IN THE FIELD OF PHARMACOLOGY. 1707068 276000 352525 5797721 1 1 0 0 0 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 36 0 1 23 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 0 MD VA X THE ORGANIZATION 3016347065 1801 ROCKVILLE PIKE 210 ROCKVILLE MD 20852 XINXIN DING SEC/TREAS, THEN PAST SEC/TREAS 5.00 X X 25525 0 0 MICHAEL L JARVIS PAST PRESIDENT (UNTIL 06/30/2024) 5.00 X X 0 0 0 NAMANDJE BUMPUS PRESIDENT 5.00 X X 0 0 0 KATHRYN CUNNINGHAM PAST SEC/TREAS (UNTIL 06/30/2024) 5.00 X X 0 0 0 CAROL BECK PRESIDENT ELECT 5.00 X X 0 0 0 PAM HORNBY SEC/TREAS ELECT, THEN SEC/TREAS 5.00 X X 0 0 0 RANDY HALL COUNCILOR, THEN PRESIDENT ELECT 5.00 X 0 0 0 JOHN TRAYNOR COUNCILOR, THEN SEC/TREAS ELECT 5.00 X 0 0 0 NINA ISOHERRANEN COUNCILOR 5.00 X 800 0 0 KENNETH TEW COUNCILOR, THEN SEC/TREAS ELECT 5.00 X 0 0 0 AMY ARNOLD COUNCILOR (AS OF 06/30/2024) 5.00 X 0 0 0 DAVID JACKSON EXECUTIVE OFFICER 40.00 X 326646 0 11426 ROBERT STANLEY CHIEF FINANCIAL OFFICER 40.00 X 209603 0 56289 MELISSA HUSTON MEETINGS DIRECTOR 40.00 X 155435 0 47325 MARIA PASHO JOURNAL DIRECTOR 40.00 X 162240 0 41282 LYNNE HARRIS MARKETING DIRECTOR 40.00 X 167331 0 16041 CATHERINE FRY EDUCATION DIRECTOR 40.00 X 160383 0 44884 CARTER ALLEMAN GOVT AFFAIRS & SCIENCE POL DIRECTOR 40.00 X 157358 0 6942 1365321 0 224189 9 0 1 0 FASEB 6120 EXECUTIVE BLVD STE 230 ROCKVILLE MD 20852 BENEFITS & HR SERVICES 892294 HYATT REGENCY CRYSTAL CITY 2799 RICHMOND HIGHWAY ARLINGTON VA 22202 ASPET 2024 MEETING VENUE 677418 KNOWLEDGEWORKS GLOBAL LTD PO BOX 74007142 CHICAGO IL 60674 SERVICES FOR JOURNAL PRODUCTION 394421 MPS NORTH AMERICA 5728 MAJOR BLVD STE 528 ORLANDO FL 32819 ONLINE PEER REVIEW & JOURNALS 357127 SPECTRUM FINANCIAL SERVICES PO BOX 3526 RESTON VA 20195 CONTRACT/TEMP LABOR 161908 5 20474 20474 PUBLICATIONS 513120 3370443 3350011 20432 SOCIETY MEETINGS 900099 386510 386510 MEMBER DUES 900099 352525 352525 MEETING SPONSORSHIPS 900099 83550 83550 4193028 609049 609049 10070699 8202611 1868088 1868088 1868088 MISCELLANEOUS 900099 43965 43965 43965 6734604 4216561 20432 2477137 X 276000 276000 603964 479379 124585 2142710 1700714 441996 235278 186745 48533 229350 182040 47310 177708 141051 36657 9448 4603 4845 40767 19862 20905 171042 171042 1261827 1030548 231279 55681 55681 112831 78876 33955 250076 169311 80765 185989 33035 152954 332402 304256 28146 882323 848104 34219 693 693 52106 23900 28206 58252 6915 51337 DUES & SUBSCRIPTIONS 137179 124144 13035 HONORARIA & AWARDS 75746 75746 MISCELLANEOUS 69350 56811 12539 7360722 5797721 1563001 0 1061544 265969 52953 10817 83508 76736 196772 254600 867825 667783 249034 200042 27673092 29537653 932870 770234 30249773 31116051 546225 397438 265000 1684716 2346993 57001 9740 1342880 1119074 3630822 4138245 X 24488897 24981442 2130054 1996364 26618951 26977806 30249773 31116051 -626118 984973 0 X X 0 1 X 1 0 X 36214 394918 11810 10917 20474 474333 3970176 3923669 3809481 4260409 4172596 20136331 4006390 4318587 3821291 4271326 4193070 20610664 3800 2725 2700 3600 5830 18655 0 3800 2725 2700 3600 5830 18655 20592009 502804 513143 556591 642853 609049 2824440 502804 513143 556591 642853 609049 2824440 18763 18473 12070 -1330 0 47976 3674 11088 51773 37363 43965 147863 4531631 4861291 4441725 4950212 4846084 23630943 0.87140 0.87630 0.11950 0.11490 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2020 AMOUNT: $ 3,674. 2021 AMOUNT: $ 11,088. 2022 AMOUNT: $ 51,773. 2023 AMOUNT: $ 37,363. 2024 AMOUNT: $ 43,965. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 X 1413821 950 189014 145670 1458115 1353759 1265 170884 112087 1413821 1633028 -204363 74906 1353759 1573400 235683 176055 1633028 1576460 173242 176302 1573400 0.00000 0.95329 0.04671 0 0 867825 667783 200042 200042 OPERATING LEASE LIABILITY 1111551 FINANCE LEASE LIABILITY 7523 1119074 X 7548535 984973 984973 6563562 171042 171042 6734604 7189680 0 7189680 171042 171042 7360722 PART IV, LINE 2B: THE SOCIETY ACTS IN A CUSTODIAL CAPACITY FOR IUPHAR SECTION ON DRUG METABOLISM (THE SECTION) AND AMSPC. THE SOCIETY RECEIVES FUNDS AND PAYS APPROVED EXPENSES ON BEHALF OF THE SECTION AND AMSPC. PART V, LINE 4: ORGANIZATION'S ENDOWMENT FUNDS ARE BROKEN INTO TEMPORARILY AND PERMANENTLY RESTRICTED NET ASSETS. TEMPORARILY RESTRICTED FUNDS ARE TO BE USED FOR ORGANIZATIONAL USE. PERMANENTLY RESTRICTED FUNDS ARE INTENDED TO REMAIN AND GENERATE INCOME FOR USES SPECIFIED BY THE DONOR, PRINCIPALLY FOR FELLOWSHIPS. PART X, LINE 2: THE SOCIETY IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND APPLICABLE STATE LAW. THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THAT GUIDANCE, THE SOCIETY MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES BASED ON THE TECHNICAL MERITS OF THE POSITION. EXAMPLES OF TAX POSITIONS INCLUDE THE TAX-EXEMPT STATUS OF THE SOCIETY AND VARIOUS POSITIONS RELATED TO THE POTENTIAL SOURCES OF UNRELATED BUSINESS TAXABLE INCOME (UBTI). THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THERE WERE NO UNRECOGNIZED TAX BENEFITS IDENTIFIED OR RECORDED AS LIABILITIES FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. THE SOCIETY'S POLICY WOULD BE TO RECOGNIZE INTEREST AND PENALTIES, IF ANY, ON TAX POSITIONS RELATED TO ITS UNRECOGNIZED TAX BENEFITS IN INCOME TAX EXPENSE IN THE FINANCIAL STATEMENTS. NO INTEREST AND PENALTIES WERE ASSESSED OR RECORDED DURING CALENDAR YEARS ENDED DECEMBER 31, 2024 AND 2023. THE SOCIETY'S FORMS 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR THREE YEARS AFTER THEY WERE FILED. 1 LSU HEALTH SHREVEPORT RM 1-214 PO BOX 33932 SHREVEPORT CA 71130 720702002 501(C)(3) 55200 0 INSTITUTIONAL SURF AWARD UTHSCSA 7703 FLOYD CURL DR MC 7828 SAN ANOTNIO TX 78229 741586031 501(C)(3) 55200 0 INSTITUTIONAL SURF AWARD WASHINGTON STATE UNIVERSITY 412 E SPOKANE FALLS BLVD SPOKANE WA 99202 916001108 501(C)(3) 55200 0 INSTITUTIONAL SURF AWARD PACIFIC UNIVERSITY 2043 COLLEGE WAY FOREST GROVE OR 97116 930386892 501(C)(3) 55200 0 INSTITUTIONAL SURF AWARD UNIVERSITY OF ARKANSAS 1 UNIVERSITY OF ARKANSAS FAYETTEVILLE AR 72701 716003252 501(C)(3) 55200 0 INSTITUTIONAL SURF AWARD 5 PART I, LINE 2: THE SOCIETY OFFERS AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE OUTSTANDING RESEARCH BY PROMINENT PHARMACOLOGISTS AND TO STIMULATE FUNDAMENTAL RESEARCH BY YOUNG INVESTIGATORS. BEST POSTER AWARDS ARE PRESENTED TO MEETING ATTENDEES WHO HAVE SUBMITTED AN OUTSTANDING RESEARCH ABSTRACT FOR PRESENTATION AT THE MEETING. TRAVEL AWARDS ARE GRANTED TO STUDENTS AS AN EDUCATIONAL TOOL TO ATTEND SCIENTIFIC MEETINGS. X X X X 0 0 0 0 0 0 0 0 0 DAVID JACKSON EXECUTIVE OFFICER 284895 0 41751 0 0 0 9526 0 1900 0 338072 0 0 0 ROBERT STANLEY CHIEF FINANCIAL OFFICER 209603 0 0 0 0 0 9746 0 46543 0 265892 0 0 0 CATHERINE FRY EDUCATION DIRECTOR 160383 0 0 0 0 0 22007 0 22877 0 205267 0 0 0 MARIA PASHO JOURNAL DIRECTOR 162240 0 0 0 0 0 4057 0 37225 0 203522 0 0 0 MELISSA HUSTON MEETINGS DIRECTOR 155435 0 0 0 0 0 3986 0 43339 0 202760 0 0 0 LYNNE HARRIS MARKETING DIRECTOR 167331 0 0 0 0 0 11584 0 4457 0 183372 0 0 0 CARTER ALLEMAN GOVT AFFAIRS & SCIENCE POL DIRECTOR 157358 0 0 0 0 0 5511 0 1431 0 164300 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 MEMBERSHIP CONSISTS OF REGULAR MEMBERS, RETIRED MEMBERS, AFFILIATE MEMBERS, POSTDOCTORAL, AND STUDENT MEMBERS. FORM 990, PART VI, SECTION A, LINE 7A THE BOARD IS ELECTED FROM A SLATE BY ALL ELIGIBLE MEMBERS. BOARD MEMBERS ARE ALSO MEMBERS OF THE SOCIETY AND THEREFORE, CAN VOTE IN THE ELECTION THAT ELECTS THEM. FORM 990, PART VI, SECTION A, LINE 7B CHANGES TO THE BY-LAWS ARE SUBJECT TO APPROVAL BY THE MEMBERSHIP. FORM 990, PART VI, SECTION B, LINE 10B WHILE THE SOCIETY DOES NOT DIRECTLY GOVERN THE CHAPTER ACTIVITIES, IT DOES PROVIDE PROCEDURAL GUIDELINES TO THE CHAPTERS AND HAS OTHER STEPS IN PLACE TO EVALUATE THAT THE CHAPTERS ACTIVITIES ARE CONSISTENT WITH THE SOCIETY'S TAX-EXEMPT PURPOSES. SUCH AS, BUT NOT LIMITED TO: INTERESTED CHAPTER GROUPS MUST SUBMIT A PETITION TO THE SOCIETY'S EXECUTIVE OFFICER FOR APPROVAL; CHAPTERS MUST SUBMIT ANNUAL REPORTS TO THE EXECUTIVE OFFICER; THE PRESIDENT OF THE CHAPTER MUST ALSO BE A REGULAR MEMBER OF THE SOCIETY. FORM 990, PART VI, SECTION B, LINE 11B THE EXECUTIVE OFFICER REVIEWED THE RETURN AND FORWARDED COPIES TO COUNCIL MEMBERS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C EACH MEMBER OF THE COUNCIL ANNUALLY FILLS OUT THE CONFLICT OF INTEREST QUESTIONNAIRE. THE CHAIR ASKS THE COUNCIL AT THE START OF EACH MEETING IF THERE ARE ANY CONFLICTS. IF SO, THE PERSON IN CONFLICT IS ASKED TO RECUSE THEMSELVES FOR THE DISCUSSION. FORM 990, PART VI, SECTION B, LINE 15 IN 2022, THE SOCIETY CONDUCTED A PROCESS IN CONCERT WITH AN OUTSIDE HR CONSULTANT TO UPDATE JOB DESCRIPTIONS AND USE AT LEAST TWO INDEPENDENT COMPENSATION STUDIES FOR SIMILAR POSITIONS IN THE WASHINGTON METROPOLITAN AREA TO ARRIVE AT AT A COMPETITIVE SALARY FOR EACH OF THE SOCIETY'S STAFF POSITIONS. THE SOCIETY THEN WENT THROUGH A SALARY ADJUSTMENT PROCESS FOR STARTING SALARIES BEGINNING IN 2023. FORM 990, PART VI, SECTION C, LINE 19 THE FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PUBLICATIONS AND COMMISSIONS AND CONSULTING: PROGRAM SERVICE EXPENSES 836,223. MANAGEMENT AND GENERAL EXPENSES 26,739. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 862,962. CONTRACTED SERVICES: PROGRAM SERVICE EXPENSES 194,325. MANAGEMENT AND GENERAL EXPENSES 204,540. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 398,865. FORM 990, PART XII, LINE 2C: THE OVERSIGHT PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. THE FINANCE COMMITTEE REVIEWS AND APPROVES THE DRAFT AUDIT REPORT.